NANoREG D5 03

NANoREG D5.03 DR In vitro screening methodology for absorption or crossing of other barriers Acesse: https://www.rivm.nl/en/documenten/nanoreg-d503-dr-in-vitro-screening-methodology-for-absorption-or-crossing-of-other  SOPs available in deliverable: SOP 01 Protocol for organotypic cell culture modified for exposure to nanomaterials SOP 02 Caco-2 cell culture and differentiation SOP 03 Evaluation of NMs impact on Caco-2 cell barrier model

NANoREG D5.03 DR In vitro screening methodology for absorption or crossing of other barriers

Acesse:

https://www.rivm.nl/en/documenten/nanoreg-d503-dr-in-vitro-screening-methodology-for-absorption-or-crossing-of-other 

SOPs available in deliverable:

  • SOP 01 Protocol for organotypic cell culture modified for exposure to nanomaterials
  • SOP 02 Caco-2 cell culture and differentiation
  • SOP 03 Evaluation of NMs impact on Caco-2 cell barrier model

Similar Posts